Sunzen Biotech Berhad reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was MYR 28.43 million compared to MYR 23.65 million a year ago. Net income was MYR 0.741 million compared to net loss of MYR 0.218 million a year ago. Basic earnings per share from continuing operations was MYR 0.0012 compared to basic loss per share from continuing operations of MYR 0.0004 a year ago. Diluted earnings per share from continuing operations was MYR 0.0011 compared to diluted loss per share from continuing operations of MYR 0.0004 a year ago.